- Previous close
0.0040 - Open
0.0030 - Bid 0.0030 x --
- Ask 0.0040 x --
- Day's range
0.0030 - 0.0040 - 52-week range
0.0030 - 0.0070 - Volume
300,100 - Avg. Volume
152,539 - Market cap (intra-day)
6.012M - Beta (5Y monthly) 0.53
- PE ratio (TTM)
-- - EPS (TTM)
-0.0000 - Earnings date 8 Aug 2024
- Forward dividend & yield --
- Ex-dividend date 30 Apr 2014
- 1y target est
--
AJJ Medtech Holdings Limited provides providing MedTech integrated solutions to healthcare sector in Singapore. It supplies medical devices with complementary digital, artificial intelligence (AI), and robotics solutions to customers and supplying partners. The company offers in-vitro diagnostics, including point of call diagnostics with focus on at-home monitoring and diagnostics, including blood glucose monitoring system and single-use test kits, as well as laboratory diagnostics and biobanking solutions with focus on solutions on diagnostics and academic research. The company also provides clinical stage cancer treatment device, including high-intensity focused ultrasound (HIFU), general and plastic surgery devices, and ward-side consumables. In addition, it distributes Samsung Medison ultrasound products; and dental supplies and intra-oralscanners, as well as provides management consultancy services for healthcare organizations. The company was formerly known as OEL (Holdings) Limited and changed its name to AJJ Medtech Holdings Limited in February 2024. AJJ Medtech Holdings Limited was incorporated in 1984 and is based in Singapore.
www.ajjmedtech.com.sg--
Full-time employees
31 December
Fiscal year ends
Healthcare
Sector
Medical Devices
Industry
Related news
View more
Performance overview: 584.SI
Trailing total returns as of 05/11/2024, which may include dividends or other distributions. Benchmark is
.YTD return
1-year return
3-year return
5-year return
Compare to: 584.SI
Select to analyse similar companies using key performance metrics; select up to four stocks.
Statistics: 584.SI
View moreValuation measures
Market cap
6.01M
Enterprise value
7.68M
Trailing P/E
--
Forward P/E
--
PEG ratio (5-yr expected)
--
Price/sales (ttm)
1.76
Price/book (mrq)
15.90
Enterprise value/revenue
3.12
Enterprise value/EBITDA
--
Financial highlights
Profitability and income statement
Profit margin
-104.76%
Return on assets (ttm)
-39.00%
Return on equity (ttm)
-745.01%
Revenue (ttm)
2.46M
Net income avi to common (ttm)
-2.57M
Diluted EPS (ttm)
-0.0000
Balance sheet and cash flow
Total cash (mrq)
86k
Total debt/equity (mrq)
353.74%
Levered free cash flow (ttm)
-804.25k